[Form 4] CHEVRON CORP Insider Trading Activity
Chevron executive Andrew Benjamin Walz, President, DM&C, exercised stock options for a total of 11,600 shares of Chevron common stock on March 2, 2026, at exercise prices of $110.37 and $88.20 per share.
Rhea-AI Filing Summary
Chevron executive Andrew Benjamin Walz, President, DM&C, exercised stock options for a total of 11,600 shares of Chevron common stock on March 2, 2026, at exercise prices of $110.37 and $88.20 per share. He then sold 11,600 shares of common stock in open-market transactions at weighted-average prices around $188.56–$188.61, reducing his directly held common stock to zero. As of the filing, he reported 8,805 shares held indirectly through a Chevron 401(k) employee savings investment plan.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Non-Qualified Stock Option (Right to Buy) | 6,600 | $0.00 | $0.00 |
| Exercise | Non-Qualified Stock Option (Right to Buy) | 5,000 | $0.00 | $0.00 |
| Exercise | Common Stock | 6,600 | $110.37 | $728K |
| Exercise | Common Stock | 5,000 | $88.20 | $441K |
| Sale | Common Stock | 6,600 | $188.5556 | $1.24M |
| Sale | Common Stock | 5,000 | $188.61 | $943K |
| holding | Common Stock | -- | -- | -- |
Footnotes (4)
- F1. This transaction was executed in multiple trades at prices ranging from $188.50 to $188.64. The price reported in Column 4 reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the range provided.
- F2. Between February 19, 2026 and March 2, 2026, the reporting person acquired 3 shares of Chevron common stock under the Chevron Employee Savings Investment Plan, a 401(k) Plan.
- F3. Option granted 1/29/2020. One-third of the shares subject to the option vested on January 31, 2021, January 31, 2022 and January 31, 2023, respectively.
- F4. Option granted 1/27/2021. One-third of the shares subject to the option vested on January 31, 2022, January 31, 2023 and January 31, 2024, respectively.
AI-generated analysis. How Rhea-AI works. Not financial advice.